PRIMAQUINE diphosphate, eq. 7.5mg base, tab.

STD DORAPRIM7T-

Valid Article

Former Code(s): DORAZBE0060 DORAZBD0011

Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
P01BA03
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.

OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

https://unicat.msf.org/web/image/product.template/571336/image_1920?unique=1697db5

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

PRIMAQUINE

Therapeutic Action

Antimalarial

Indications

Radical cure (prevention of relapses) in patients with uncomplicated Plasmodium vivax or P. ovale malaria.

In low-transmission areas, reduction of the transmission in patients with P. Falciparum infection, in association with an artemisinin-based combination therapy (ATC).

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Qualitative and semi-quantitative test (near-patient) to determine the status of G6PD of patients should be available to guide the administration of primaquine.

Precautions for Use

Contraindicated:

  • during pregnancy
  • in women breastfeeding infants aged < 1 month
  • in infants aged < 1 month
  • in people with G6PD deficiency

Storage

Below 25ºC